A large study led by Lund University in Sweden has shown that people with Alzheimer’s disease can now be identified before they experience any symptoms.
The Housing Learning and Improvement Network looks at the design process and philosophy behind creating a successful Extra Care scheme.
Researchers find people living in towns with lots of green space were least likely to have Alzheimer’s or Parkinson’s.
Taking a daily multivitamin supplement can slow age-related memory decline, researchers found.
The US Food and Drug Administration has announced the supplemental approval of Rexulti (brexpiprazole) oral tablets for the treatment of agitation associated with dementia due to Alzheimer’s. Learn more.
Meet ElliQ, a friendly little robot companion to brighten the days of older adults who spend most of their time at home.
Researchers find that people with dementia who received the drug suvorexant showed a drop in tau and amyloid beta. The drug is already available for sleep problems in Alzheimer’s. Learn more.
Canada’s first dementia village enables its inhabitants to live their lives in freedom and dignity, while ensuring they have person-centered care. Learn more.
Research shows that lecanemab is the first drug ever to slow cognitive decline in Alzheimer’s. Learn more.
The FDA has approved the supplemental New Drug Application (sNDA) of REXULTI® (brexpiprazole) for the treatment of agitation associated with Alzheimer’s. It’s the first such treatment to be approved in the US. Learn more.
FILM SHORT: Meet 6 people living fulfilling lives with dementia. This award-winning, true film explores the needs and feelings of real people with dementia.
UCLA CAREGIVER TRAINING VIDEO: Agitation and anxiety create resistance in people with Alzheimer’s and frustration for their caregivers. Learn techniques to solve and resolve these difficult moments.
In dementia, quality light improves mood, awareness and vision. Therapeutic lamps go further, reducing Alzheimer’s agitation, getting sleep cycles on schedule and easing depression. See the benefits.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
It looks like a sneeze cannot give anyone Alzheimer’s. While Alzheimer’s abnormal disease proteins do spread from cell-to-cell, they are not “infectious”. Check out the facts.
No spam, only news and updates.
